403 related articles for article (PubMed ID: 35142071)
41. Progress of stimulus responsive nanosystems for targeting treatment of bacterial infectious diseases.
Yang N; Sun M; Wang H; Hu D; Zhang A; Khan S; Chen Z; Chen D; Xie S
Adv Colloid Interface Sci; 2024 Feb; 324():103078. PubMed ID: 38215562
[TBL] [Abstract][Full Text] [Related]
42. Intelligent design of polymersomes for antibacterial and anticancer applications.
Wang T; Qin J; Cheng J; Li C; Du J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Sep; 14(5):e1822. PubMed ID: 35673991
[TBL] [Abstract][Full Text] [Related]
43. The Smart Drug Delivery System and Its Clinical Potential.
Liu D; Yang F; Xiong F; Gu N
Theranostics; 2016; 6(9):1306-23. PubMed ID: 27375781
[TBL] [Abstract][Full Text] [Related]
44. Recent advances in dual- and multi-responsive nanomedicines for precision cancer therapy.
Zhang Y; Li J; Pu K
Biomaterials; 2022 Dec; 291():121906. PubMed ID: 36395660
[TBL] [Abstract][Full Text] [Related]
45. Stimuli-responsive and cellular targeted nanoplatforms for multimodal therapy of skin cancer.
Padya BS; Pandey A; Pisay M; Koteshwara KB; Chandrashekhar Hariharapura R; Bhat KU; Biswas S; Mutalik S
Eur J Pharmacol; 2021 Jan; 890():173633. PubMed ID: 33049302
[TBL] [Abstract][Full Text] [Related]
46. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
47. Recent advances of polymeric nanoplatforms for cancer treatment: smart delivery systems (SDS), nanotheranostics and multidrug resistance (MDR) inhibition.
Gupta U; Maity D; Sharma VK
Biomed Mater; 2023 Nov; 19(1):. PubMed ID: 37944188
[TBL] [Abstract][Full Text] [Related]
48. Stimuli-Responsive Release of Antimicrobials Using Hybrid Inorganic Nanoparticle-Associated Drug-Delivery Systems.
Moorcroft SCT; Jayne DG; Evans SD; Ong ZY
Macromol Biosci; 2018 Dec; 18(12):e1800207. PubMed ID: 30318831
[TBL] [Abstract][Full Text] [Related]
49. Engineering hybrid nanosystems for efficient and targeted delivery against bacterial infections.
Elhassan E; Devnarain N; Mohammed M; Govender T; Omolo CA
J Control Release; 2022 Nov; 351():598-622. PubMed ID: 36183972
[TBL] [Abstract][Full Text] [Related]
50. Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: Role of surface engineered nanocarriers.
Gopalan D; Pandey A; Udupa N; Mutalik S
J Control Release; 2020 Mar; 319():183-200. PubMed ID: 31866505
[TBL] [Abstract][Full Text] [Related]
51. Recent Progress in Stimuli-Responsive Intelligent Nano Scale Drug Delivery Systems: A Special Focus Towards pH-Sensitive Systems.
Sethuraman V; Janakiraman K; Krishnaswami V; Kandasamy R
Curr Drug Targets; 2021; 22(8):947-966. PubMed ID: 33511953
[TBL] [Abstract][Full Text] [Related]
52. pH-Responsive Lipid-Dendrimer Hybrid Nanoparticles: An Approach To Target and Eliminate Intracellular Pathogens.
Maji R; Omolo CA; Agrawal N; Maduray K; Hassan D; Mokhtar C; Mackhraj I; Govender T
Mol Pharm; 2019 Nov; 16(11):4594-4609. PubMed ID: 31593478
[TBL] [Abstract][Full Text] [Related]
53. Stimulus-Responsive Drug Delivery Nanoplatforms for Osteoarthritis Therapy.
Jiang Q; Zhang S
Small; 2023 Jun; 19(23):e2206929. PubMed ID: 36905239
[TBL] [Abstract][Full Text] [Related]
54. Micro-/Nanorobots in Antimicrobial Applications: Recent Progress, Challenges, and Opportunities.
Zhang Z; Wang L; Chan TKF; Chen Z; Ip M; Chan PKS; Sung JJY; Zhang L
Adv Healthc Mater; 2022 Mar; 11(6):e2101991. PubMed ID: 34907671
[TBL] [Abstract][Full Text] [Related]
55. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
Du JZ; Li HJ; Wang J
Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
[TBL] [Abstract][Full Text] [Related]
56. Enzyme-triggered smart antimicrobial drug release systems against bacterial infections.
Zhou Q; Si Z; Wang K; Li K; Hong W; Zhang Y; Li P
J Control Release; 2022 Dec; 352():507-526. PubMed ID: 36341932
[TBL] [Abstract][Full Text] [Related]
57. Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment.
Zhang W; Hu E; Wang Y; Miao S; Liu Y; Hu Y; Liu J; Xu B; Chen D; Shen Y
Int J Nanomedicine; 2021; 16():6141-6156. PubMed ID: 34511911
[TBL] [Abstract][Full Text] [Related]
58. Smart delivery systems for microbial biofilm therapy: Dissecting design, drug release and toxicological features.
Sousa A; Phung AN; Škalko-Basnet N; Obuobi S
J Control Release; 2023 Feb; 354():394-416. PubMed ID: 36638844
[TBL] [Abstract][Full Text] [Related]
59. Smart chitosan-based microgels for enhanced photothermal-assisted antibacterial activity.
Gong H; Liu L; Zhou J; Li H; Qiu J; Cheng W
Int J Biol Macromol; 2023 Dec; 252():126389. PubMed ID: 37611687
[TBL] [Abstract][Full Text] [Related]
60. Cell membrane-coated nanoparticles for the treatment of bacterial infection.
Ma J; Jiang L; Liu G
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Sep; 14(5):e1825. PubMed ID: 35725897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
